IN001 mRNA Vaccine

IN001 mRNA vaccine · Shenzhen Shenxin Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IN001 mRNA Vaccine, covering 2025-10-07 to 2025-10-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants [Phase 2]

See pricing